News

Public · Published

B. Riley Securities maintains Core Scientific at Buy, lowers price target to $27 from $31

B. Riley Securities kept its Buy rating on Core Scientific but cut its price target to $27 from $31, a 12.9% decrease. The new target implies 129.6% upside from the November 6 closing price of $11.76. Five recent analyst targets ranged from $25 to $36.

Published:

Updated:

What happened

B. Riley Securities kept its Buy rating on Core Scientific but cut its price target to $27 from $31, a 12.9% decrease. The new target implies 129.6% upside from the November 6 closing price of $11.76. Five recent analyst targets ranged from $25 to $36.

Confirmed

Global impact / market context

The lower target signals that B. Riley sees less potential value than before, while retaining its Buy view. Analyst targets can shape investor expectations and positioning, but they are estimates rather than company results; the article gives no change to Core Scientific’s revenue, costs, or cash available.

Analyst inference

The five recent analyst targets span $25 to $36, showing differing views on Core Scientific’s value. B. Riley’s revised $27 target sits within that range. These recommendations provide a snapshot of analyst opinion, not evidence that the company’s operations or share price have changed.

Confirmed

What to watch

  1. Watch for subsequent analyst rating or target changes, especially whether other firms revise their estimates; such updates could shift investor expectations without changing company performance. Analyst inference
  2. Compare future company results with the assumptions behind analyst targets, including revenue and costs, if the company reports those measures in later updates. Analyst inference
  3. The article reports no operating or financial change alongside B. Riley’s target cut, so any view of business impact remains unconfirmed by this update. Confirmed

Evidence

  • Original source link unavailable